Section 28: Procedure granting approval

With respect to any decision taken under section 23 of this Act, the Agency:(a) shall take into consideration, the relevant comments, inputs or concerns of the public received under the provisions of this Act;
(b) shall notify the applicant in writing and the Biosafety clearing house of the decision and information, facts and analysis supporting the decision;
(c) shall notify the public of any genetically modified organism for which approval or permit has been granted for import , contained use, confined field trials, multi-locational trials or commercial release and provide the information, facts and analysis supporting the decision;
(d) may specify the steps to be taken in the implementation of the risk management plan where there are potential risk to human health, animal, plant and the environment.
(e) may in respect of any approval for import, transit, contained use, confined field trial, multi-locational trials or commercial release of any genetically modified organisms, direct the applicant to carry out monitoring and evaluation of risk for a specified period equivalent to the life cycle of the relevant species or for such period as the Director General may, from time to time, determine;
(f) impose any additional measure for risk management as provided in this Act;
(g) do such other things as take such other steps as he may consider necessary and expedient for carrying into effect this decision.